This is in line with existing data (Gober et al., 2003; Yao et al., 2019; Kim et al., 2020) and indicates that HSPB8 functions as a tumor suppressor gene during the initiation and progression of prostate cancer. Here, HSPB8 is linked to prostate carcinoma.